Abivax (ABVX) Depreciation & Amortization (CF) (2024 - 2026)

Abivax's Depreciation & Amortization (CF) history runs 3 years deep, the most recent figure standing at $429663.7 for Q1 2026.

• In Q1 2026, Depreciation & Amortization (CF) rose 49.62% year-over-year to $429663.7; the TTM figure through Mar 2026 stood at $1.4 million (up 8.47% YoY), while the FY2025 annual figure was $1.2 million, up 6.16% from the prior year.
• Depreciation & Amortization (CF) was $429663.7 for Q1 2026 at Abivax, up from $321276.0 in the prior quarter.
• In the past five years, Depreciation & Amortization (CF) ranged from a high of $429663.7 in Q1 2026 to a low of $229222.3 in Q1 2024.
• Historically, Depreciation & Amortization (CF) has averaged $314410.8 across 3 years, with a median of $298138.1 in 2024.
• The sharpest annual moves came in 2025 and 2026: Depreciation & Amortization (CF) dropped 27.72% in 2025, then jumped 49.62% in 2026.
• A 3-year view of Depreciation & Amortization (CF) shows it stood at $298138.1 in 2024, then advanced by 7.76% to $321276.0 in 2025, then jumped by 33.74% to $429663.7 in 2026.
• The last three Depreciation & Amortization (CF) figures came in at $429663.7 (Q1 2026), $321276.0 (Q4 2025), and $317983.0 (Q3 2025), per Business Quant data.